Obstetrics & Gynecology, Gynecologic Oncology · Portland, OR
NPI
1245551845
Since 2010
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9555 SW Barnes Rd
Portland, OR, 97225
Phone (503) 297-7403
Groups this clinician bills Medicare through
Medicare paid, 2024
$955K
55,931 services
Medicare patients, 2024
213
Average age 72
Drug cost, 2024
$1.6M
553 prescriptions
Company payments, 2025
$283
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin A Salinas was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 8,670 times for 13 patients. In total Erin A Salinas billed 55,931 services in 159 codes, and Medicare paid $955K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 8,670 | 13 | $0.27 | $2,334 |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,194 | 11 | $0.08 | $574 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,580 | 25 | $0.10 | $264 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,070 | 30 | $0.09 | $92.93 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 571 | 15 | $0.69 | $395 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 510 | 20 | $0.25 | $125 |
| J9045 Injection, carboplatin, 50 mg | Office | 429 | 13 | $2.81 | $1,206 |
| 85025 Blood Count | Office | 316 | 52 | $7.61 | $2,405 |
| 80053 Clinical Chemistry | Office | 307 | 50 | $10.35 | $3,177 |
| 86304 Immunoassay | Office | 289 | 67 | $20.39 | $5,893 |
| 96375 Injection Administration | Office | 212 | 32 | $12.43 | $2,635 |
| 83735 Clinical Chemistry | Office | 186 | 23 | $6.57 | $1,222 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 176 | 11 | $0.41 | $72.31 |
| 96367 Intravenous Infusion, Hydration | Office | 171 | 28 | $22.70 | $3,881 |
| 99214 Office E&M - Established | Office | 159 | 75 | $97.21 | $15K |
By year: 2022 $480K for 51,442 services; 2023 $577K for 50,672 services; 2024 $955K for 55,931 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 316 | 52 | $7.61 | $2,405 |
| 80053 Clinical Chemistry | 307 | 50 | $10.35 | $3,177 |
| 86304 Immunoassay | 289 | 67 | $20.39 | $5,893 |
| 83735 Clinical Chemistry | 186 | 23 | $6.57 | $1,222 |
| 36415 Venipuncture Blood Collection | 130 | 63 | $8.65 | $1,125 |
| 81002 Clinical Chemistry | 73 | 11 | $3.41 | $249 |
| 84443 Clinical Chemistry | 53 | 14 | $16.46 | $872 |
| 81003 Clinical Chemistry | 32 | 11 | $2.20 | $70.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Erin A Salinas prescribed most often to Medicare patients was Zejula (Niraparib Tosylate), with 55 prescriptions and refills. In total Erin A Salinas wrote 553 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zejula Niraparib Tosylate | 55 | 55 | Under 11 | $970K |
| Letrozole Generic | 46 | 96 | 13 | $791 |
| Eliquis Apixaban | 45 | 52 | Under 11 | $30K |
| Ondansetron Hcl Generic | 43 | 43 | 33 | $511 |
| Oxycodone Hcl Generic | 37 | 37 | 35 | $173 |
| Lynparza Olaparib | 35 | 37 | Under 11 | $373K |
| Prochlorperazine Maleate Generic | 34 | 34 | 29 | $389 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 26 | 26 | 19 | $358 |
| Gabapentin Generic | 18 | 18 | Under 11 | $91.74 |
| Enoxaparin Sodium Generic | 14 | 14 | 14 | $1,530 |
| Estradiol (Twice Weekly) Estradiol | 13 | 20 | Under 11 | $1,366 |
| Tamoxifen Citrate Generic | 12 | 34 | Under 11 | $346 |
Brand drugs: 161 claims; generic drugs: 392 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin A Salinas $283 ($283 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $266.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.